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Summary: The continuous spectröphotometric assay of 5'-nucleotidase originally described by Heinz et al.
((1980) J. Clin. Chem. Clin. Biochem. 18, 781-788) was modified and fully automated on a Kem-O-Mat
transfer analyzer, using inosine S'-monophosphate äs Substrate. The reaction product was hydrogen peroxide
and the redüction of NADP was observed for 10 minutes at 340 nm and at a reaction temperature of 30 °C.
The different factors involved in the enzyme reaction were checked, including the Substrate concentration,
reaction rate, linearity and Substrate preservatiort. Normal values ranged from l to 13 U/1. Between-day
reproducibility was estimated with two different commercial control serä, and the coefficient of Variation was
5% for the upper limit of normal activity (23 U/l). There was good agreement between the present method
and a semi-automätic colorimetric technique (for 100 sera tested by both methods, the correlation coefficient
was 0.974 and the regression line equation, y = 0.85 x-1.5). Despite the lengthy reagent mixture preparation
procedure, the method permitted assay of 50 samples per hour. The occurrence of high serum blanks in
certain pathological states is discussed.
Kontinuierliche Bestimmung der katalytischen Aktivität von 5'±Nucleotidase im Serum mit Inosin-5'-mono-
phosphat als Substrat und völliger Mechanisierung mit einem Transfer-Analyser (Kem-O-Mat)
Zusammenfassung: Die kontinuierliche Methode zur spektrophotometrischen Bestimmung der 5'-Nucleoti-
•dase nach Heinz et al. ((1980) J. Clin. Chem. Clin. Biochem. 18, 781-788) wurde modifiziert und mit Inosin-
S'-monophosphat als Substrat am Kem-O-Mat Transfer-Analyser voll mechanisiert. Die an das Zwischen-
produkt Wasserstoffperoxid gekoppelte Reduktion von NADP wurde für 10 min bei 340 nm und 30 °C ver-
folgt. Verschiedene Einflußgrößen auf die enzymatische Reaktion wurden untersucht, eingeschlossen Sub-
stratkonzentration, Reaktionsgeschwindigkeit, Linearität und Substratkonservierung. Werte bei Gesunden
lagen im Bereich von l —13 U/l. Die Reproduzierbarkeit von Tag zu Tag wurde mit zwei verschiedenen
käuflichen Kontrollseren ermittelt. Der Variationskoeffizient betrug 5% für 23 U/l. Es bestand eine gute
Übereinstimmung zwischen den mit der vorgeschlagenen und einer teilmechanisierten kolorimetrischen
Methode ermittelten Werten (n = 100, r = 0,974, y = 0,85x~l,5). Abgesehen von der zeitaufwendigen
Reagenzbereitung erlaubt die Methode die Bestimmung von 50 Proben je Stunde. Das Auftreten hoher
Leerwerte im Serum bei bestimmten pathologischen Zuständen wird diskutiert.
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Introduction
5'-Nucleotidase (EC 3.1.3.5) is used äs a biological
marker in hepatobiliary disturbances; an increase in
its catalytic activity in the serum is usually accom-
panied by a concomitant rise in serum alkaline phos-
phatase. In hyperphosphatasaemia, the hepatic spe-
cificity of 5'-nucleotidase enables it to be used to dis-
tinguish between the different etiologies of this con-
dition, which may be hepatic, osseous, placental or
intestinal.
Many methods of measuring its activity have been
suggested. The oldest use adenosine S'-monophos-
phate, a physiological Substrate of 5;-nucleotidase.
In this reaction
A j · £·/ i_ i. * · ¥ T ^ S'-nuc!eotidaseAdenosine 5 -monophosphate + HiO — -^*-
alkaline phosphatase
Adenosine -l· Inorganic phosphorus.
The methods suggested differ, depending on how the
reaction product is evaluated. Campbell (1) deter-
mined the inorganic phosphorus according to Fiske-
Subarow, and HUI & Sammons (2) adapted the latter
authors' procedure to a Technicon Autoanalyzer L
Since these methods proved insufficiently sensitive,
various other authors (3, 4) proposed measuring the
adenosine formed in the presence of adenosine
deaminase (EC 3.5.4.17), the reaction being äs foN
lows:
Adenosine adenosinedeaminase - Inosine +
Kalckar (5) measured the amount of adenosine
which had disappeared at 265 nm; whefeas Persijn
et. al. (6) and Belfield et al. (7) estimated the quanti-
ty of ammonia formed by Berthelofs colorimetric
phenol hypochlorite reaction. More recently, Ellis et
al. (8) and Bootsma et al. (9) suggested measuring
the ammonia continuously by the action of a glutam-
ate dehydrogenase, a procedure which the same au-
thors adapted to the LKB 8600 device (10).
To avoid the drawbacks involved in endogenous am-
monia generation (4), inosine 5'-monophosphate
has been used äs Substrate. The inosine thus formed
is degraded into hypoxanthine arid then into uric
acid, according to the following reaction scheine:
Inosine 5'-monophosphate -h H2O 5'-nucleotidaseor
non specific
phosphatases
Inosine + Inorganic phosphate
Inosine H- inorganic phosphorus nucleoside
phosphorylase
Hypoxanthine + Ribose-1-P
Hypoxanthine + 2 H2O + 2 O2 xanthine oxidas;
Uric acid + 2
Dooley & Racich (11) evaluated the uric acid formed
at 293 nm directly, a technique aidäptable to the
Ceritrifichem System. Heinz et al. (12) measured the
hydrogen peroxide formed using the catalase/alde-
hyde dehydrogenase System, giving the following
reactions:
2 H2Ö2 + 2 Ethanol catalase 2 Acetaldehyde* 4 H2O
2 Acetaldehyde + NADP+ + 2 H2O
2 Acetic acid * 2 NADPH + 2 H+.
All the authors qupted endeavoured tp solve the
problem of the specificity of adenosine 5'^inono*
phosphate and inosine 5'-monophosphate hydroly-
sis. Campbell (1) used differential 5'^nucleotidase
Inhibition by nickel salts. Ariother possibility is the
use of the "enzyme diversion" technique involvirig
highly concentrated diversion Substrates preferen^
tially hydrolysed by non-specific phosphatases; for
this purpose Belfield et al. (7) used iß-glycerophos-
phate at a conceritration 50 times higher thari that öf
the adenosine 5'-monophosphate, without any in-
hibitory effect on the S'-riticleptidase. Persijn et al.
(3) advocated the use of phenyl phosphate, for which
non-specific phosphatases have a higher afflnity than
for ß-glycerophpsphate. The cpncentrations öf the
latter used by Dooley & Racich'(11) & Heinz et al.
(12) were respectively 25 and 100 times higher thari
those of the inosine 5'-monophosphate.
The purpose of the present work was tp ädäpt the
continuous technique of Heinz et al. (12) to a trans-
fef anälyzer. Owirig to the technical specifications of
this device, we had to modify the methpd and the
different parameters of the enzyme reaction. Auto·^
mation was carried out at 340 nm arid 30 °C ori. a
Coultronics Kem-O-Mat transfer apparatus con-
nected to a Tektronix 31 cälculator.
Materials and Methode
Reagents
Stock Solutions
Buffer I: 04 mol/1 triethanolamine (Bgehringer Mannheiin) pH
7.5, containirig 0.1 mol/1 KCl and l EDTA
Buffer H: 0.1 mol/1 triethanolamine (Böehringer Mannheim) pH
7.5, containing 0.1 mol/1 KCl
0.1 mol/1 KCl (Merck)
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l mol/1 KH2PO4 (Prolabo)
l mol/1 MgCl2 x 6 H2O (Merck)
0.01 mol/1 inosine 5'-monophosphate (Boehringer Mannheim
106704): 5 mg are dissolved in l ml triethanolamine buffer II
Absolute ethanol (Merck); D = 0.789 kg/l; Mr = 46.07
NADP+ (Boehringer Mannheim 128040) Mr = 787.4
Sodium ß-glycerophosphate (Merck 4168); Mr = 306.12
7 U/mg aldehyde dehydrogenase (EC 1.2.1.5) (Sigma A 6758)
20g/l (about 65000U/mg) catalase (EC 1.11.1.6) (Boehringer
Mannheim 106810)
5 g/l (about 20 U/mg) nucleoside phosphorylase (EC 2.4.2.1)
(Boehringer Mannheim 107964)
10 g/l (about 0.4 U/mg) xanthine oxidase (EC 1.2.3.2) (Boehrin-
ger Mannheim 110422)
The xanthine oxidase Suspension was dialysed overnight at +4 °C
against 0. l mol/1 KC1. At +4 °C, the dialysed enzyme was stable
for one week.
Reaction buffer
6 ml of triethanolamine buffer I was combined with 12 ml bidis-
tilled water and nine other agents were added in the order in
which they are specified below: 0.66 ml ethanol, 6.6 ul catalase,
3.5mg NADP+, 170mg sodium ß-glycerophosphate, 13.5 !
KH2PO4, 0.1 ml MgCh, 4.5mg aldehyde dehydrogenase, 93 ul
nucleoside phosphorylase and 0.66ml xanthine oxidase.
This reaction mixture, prepared äs required, remained stable for 4
hours at -f40C.
Concentration of constituents
The concentrations of the constituents of the reaction buffer are
given in table l, and the composition of the reaction medium is
indicated in table 2.
Control sera
Decision serum (Beckman Level 3, Cat. 660410).
5'ND (Control E, Sigma, Cat. N 1009).
Methodology
Prindple
For analysis, serum was diluted 1/10 in reaction buffer and the
mixture was preincubated at 30 °C for 15 minutes.
During preincubation, a slight increase in absorbance was ob-
served; this .constituted the reaction blank, which was automati-
cally substracted from sample values.
The reaction was started by adding inosine 5'-monophosphate.
Programming on Kem-O-Mal transfer apparatus
The soft roütine parameters were the following:
450 ul
49.5 ]
20
15 (I revolution
25
100 U/l
168.6
30 °C
340 nm
= 64s)
Reaction buffer
Sample
Substrate added at revolution No. 15
First reading at revolution No.
Second reading at revolution No.
Linearity limit
Calibration coefficient
Temperature
Filter
Calculation of the results
The Tektronix calculator used gave the U/l value directly after
deduetion of the reaction blank, which constituted a control for
the validity of the reagents.
One unit of 5'-nucleotidase was defined äs the amount of enzyme
which transformed l umol of inosine 5'-monophosphate in one
minute at 30 °C.
Resulfs
Activity of xan th ine oxidase after dialysis
After dialysis, xanthine oxidase activity was mea-
süred using[8—14C]hypoxanthine äs Substrate (13),
giving the reactions:
Tab. 1. Composition and concentration of components in reaction buffer.
Quantities Concentrations
ml mg U mmol/1 U /l
Distilled water
Buffer I (pH = 7.5)
containing
Triethanolamine (0.1 mol/1)
KC1 (0.1 mol/1)
EDTA (1 mmol/1)
Ethanol
NADP
Sodium ^-glycerophpsphate
KH2PO4(1 mol/1)
MgCl2x6H2O(lmol/l)
Aldehyde dehydrogenase (7 U/mg)
Nucleoside phosphorylase (100 kU/1)
Catalase (1, 3 X 109U/1)
Xanthine oxidase (=* 3 kÜ/1)
12
6
0.66
3.5
170
0.0135
0.1
4.5
0.093
0.0066
0.66
19.5331
30
30
0.3
570
0.21
28.43
0.67
5.2
32
9.3
8600
2
1612
476
438000
102
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[8-l4C]hypoxanthine
[8-14C]xanthine
 oxidasc
[8-14C]xanthine
!
"""
hincf8-14C]uric acid.L J
Oxidation products were separated by thin layer
chromatography on MN polygram cellulose and lo-
cated by autoradiography. The ratio of the radioac-
tivity of (hypoxanthine + xanthine + uric acid) spots
was used to calculate xanthine oxidase activity. The
amount of xanthine oxidase was expressed in U/l.
The xanthine oxidase activities measured in three
samples were respectively 2.8 U/l, 2.99 U/l and 3.6
U/l; the level of activity found after dialysis was
therefore fairly constant.
5'-IMP concentrations
5'-Nucleotidase was measured with increasing in-
osine S'-monophosphate concentrations rariging
from 19 to 385 μιηοΐ/ΐ.
The Lineweaver-Burk plot of 1/[S] versus l/v, ex-
pressed s U/l, was a straight line and allowed calcu-
lation of an apparent Km value of 12 μιηοΐ/l (fig. 1).
Inhibi t ion of inosine S'-monophosphate hy-
drolysis
Our purpose was to study the first analytical Step of
the rection scheine described by Heinz et al. (12).
0 25 50
rjrt l /mmol]
0
Fig. 1.
0.1 0.2 0.3
IMP (mmol/l)
Q.4
Effect of inereasing inosine S'-monophosphate concentra-
tions. The assay System was tested with increasing concen-
trations of inosine S^monpphosphate from 19 to 385
μπιοΐ/ΐ.
Inset: double reciprocal plot of S'-ii cleotidase activity
versus inosine S'-monophosphate concentrations.
Principle
[8—14C]Inosine S'-monophosph te is choseri s Sub-
strate; it is hydrolysed by 5'*nucleotidase and non-^
specific alkaline phosphatases to yield [8^14C]ino-
sine and inorganic phosphate. Glycerol 2-phosphate
acts s "divefsion Substrate", it is preferehtially hy-
drolysed by non-specific alkaline phosphatases.
Tab. 2. Composition and concentration of components in reaction mixture.
Reagents Mass of components and catalytic
activity in the cuvette
U μιηοΐ
Final concentrations of
coriiporients and
catalytic concentration
in reaction mixture
U/l mmol/l
Buffer l (pH = 7.5)
containing
Triethanolamine
KC1
EDTA
Ethanol
NADP
Sodium -glycerophosphate
KH2P04
MgCl2x6H2O
Aldehyde dehydrogenase
Nucleoside phosphorylase
Catalase
Xanthine oxidase
Sample
Inosine S'-monophosphate
450
13.5
13,5
0.135
259
0.096
12.8
0.305
2.34
0.739
0.214
197
0.045
49.5
20 0.2
519.5
26
26
0.26
499
0.185
24i65
0.587
4.50
1428
414
380000
89
0.385
.
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Assay
A working Substrate solution is prepared s follows:
330 μτηοΐ/ΐ [8—14C]inosine 5'-monophosphate (spe-
cific activity: 111 MBq/mmol = 3 mCi/mmol) is dis-
solved in a 0.1 mol/1 triethanolamine buffer pH 7.5:
the reaction mixture contains also 6 mmol/1 magne-
sium Chloride and 28 mmol/1 glycerol 2-phosphate.
After 15 minutes incubation at 30 °C, the reaction is
stopped with 150 g/kg perchloric acid. Nucleotide
and nucleoside are separated by paper ehromatogra-
phy; the chromatogram is cut and radioactivity is
measured with a liquid scintillation counter.
5'-Nucleotidase Inhibition
αϊ -Methylene adenosine 5'-diphosphate has been
recently described s a specific inhibitor of the 5'-
nucleotidase activity (15). Enzyme activity was de-
termined with increasing amounts of the inhibitor;
maximal 5'-nucleotidase Inhibition is achieved for an
inhibitor concentration higher than 250 μιηοΐ/l (fig.
2). Simultaneous use of αιβ-methylene adenosine
5'-diphosphate and glycerol 2-phosphate achieves a
nearly total Inhibition of inosine S'-monophosphate
hydrolysis. According to this assay it can be con-
cluded that glycerol 2-phosphate does act s a pow-
erful "diversion Substrate" for non-specific alkalirte
phosphatases.
= 20
0 50 250 500 . 750
α.β-M thylene adenosin-e S-diphosph -te [μπιοΐ/ΐ]
Fig. 2. Specific Inhibition of S'-nucleotidase catalytic activity by
αιβ-methylene adenosine 5'-diphosphate
χ—χ—x-!=- Serum with normal 5'-nucleotidase catalytic
concentration (8.4 U/l)
O—Φ—0— Serum with high S'-nucleotidase catalytic
concentration (26.4 U/I).
Optimal concentration of glycerol 2-phosphate
5'-Nucleotidase activity was measured with increas-
ing amounts of glycerol 2-phosphate (fig. 3): gradual
diminution of the measured catalytic activity is due
0>inσ
o 10
=3
0 10 20 30 40 50 60
Glycerol 2-phosphate lmmol / l ]
Fig. 3. Choice of an optimal glycerol 2-phosphate concentration;
S'-nucleotidase catalytic activity was measured in two sera
by adding increasing amounts of "diversion Substrate".
to the progressive effect of the "diversion Substrate".
In order to achieve a maximal Inhibition of non-spe-
cific alkaline phosphatases a 28 mmol/1 concentra-
tion was chosen (see tab. 2).
Technical performances
Kinetics
a) Preincubation phase
Reaction and serum blank absorbance (A) was ob-
served for 20 minutes; for the reaction blank, ΔΑ
was minimal and for the serum blank it was of the
order of 0.012 for normal catalytic activity. This
value was automatically deducted from the (ΔΑ) re-
corded during the reaction. The serum blank absor-
bance was stable by the lOth minute (fig. 4). For pa-
thological activity (55 U/l), the serum blank was ob-
served to be high (ΔΑ = 0.55; fig. 4).
10.5
Start
Preincubat ion Reaction
, , · · . -1
l
5
l l
10 15
Revolutions
1
20
ι ^
25
Fig. 4. Kinetic study
Kinetics during the incubation phase and enzyme reac-
tion:
Curve (l): reaction blank
Curve (2) and (3): two serum samples with normal
catalytic concentrations, respectively
4.2 and 9.1 U/l
Curve (4): serum with pathological activity
(55 U/l)
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b) Reaction kinetics
Absorbance was first read 12 seconds after adding
inosine S'-monophosphate and variations in absor^
bance were measured for ten minutes thereafter (fig.
The mean ( ) values obtained for sera with nor-
mal catalytic activity over a 10 minute period ranged
from 0.030 to 0.080. Although low, these values
were sufficiently reliable, in view of the optical per-
formances of the equipment used.
In addition, reaction kinetics were studied over a pe-
riod of 60 minutes (fig. 5). Up to 30 minutes, the
reaction was linear.
0.4
0.3
0.1
10 20 30
t Imin)
40 50 60
100
§ 75
o
l
l 50
O
3
ün
25
25 50 75
S'-NucleofidösepresenHU/l]
100
Fig. 5. Study of enzyme reaction kinetics for 60 minutes.
Fig. 6. Effect of the enzyme catalytic activity concentration.
Study pf two serum samples with high catalytic aetiyity
concentrations:
serum 1: 95 U/l
serum 2: 110 U/l.
Recovery fest
A serum control with a known S'-nucleotidäse cata-
lytic activity was added to two native human sera
whose 5'-nucleotidase activity läy in the "normal"
ränge
Serum No. 1: Measured catalytic concentration 21.3 U/l
expected catalytic concentration 22.0 U/l
recovery 96.8%
Serum No. 2: Measured catalytic concentration 41.3 U/l
expected catalytic concentration 44.0 U/I
recovery ' 93.8%
The reading time finally chosen (10 minutes 40 se-
conds = 10 revolutions) was within the linearity
zone and made it possible to combine an acceptable
degree of Variation in absorbance with the specific
requirements of the Kem-O-Mat equipment (maxi-
mum number of revolutions: 25).
Effects of 5'-nucleotidase activity
Enzyme catalytic activity was measured in 6 and 9
dilutions of two serum samples with high 5'-nucleot-
idase activity (95 U/l and 110 U/l respectively).
Each dilution was made in duplicate. Enzyme kinet-
icS were directly proportional to the catalytic con-
centration of the enzyme in the reaction rnedium
(fig. 6).
In the soft routine programmed, the linearity limit
was fixed at 10 U/l ( = 0.06 min-1).
Precision of the method
a) Repeatability
Three serum samples with increasing levels of cata-
lytic activity were analysed ten times each during the
same series of experiments (tab. 3).
For normal physiological catalytic activity, the in-
traseries coefficient of Variation was close to 5%,
and for high catalytic activity, it was 1%.
Tab. 3. Withinr-run preqision of the determination of 5'-nucleoti-
dase catalytic activity concentration (n = 10).
Mean
U/l
3.9
23.6
88
Standard deviation
U/l
0.19
0.19
0.99
Coefficient of Variation
%
4.89
0.81
1,14
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b) Reproducibility
Between-day reproducibility was estimated with
Beckman's Decision Level 3 control serum, whose
5'-nucleotidase catalytic concentration is normal
(x = 5.98 U/l) and with Sigma control serum which
has high catalytic concentration (x = 22.6 U/l).
Enzymatic activity was measured daily for 15 days.
For normal and high catalytic activities, the coeffi-
cients of Variation were 14.5 and 5% respectively.
Preservation
a) Enzyme stability
Ten samples of fresh serum were analyzed on the
day of sampling and then frozen at -20 °C. Further
tests 15 days later showed satisfactory enzyme pres-
ervation.
b) Stability of the Substrate
The preservation of the inosine 5'-monophosphate
solution was tested at +4 °C on the following:
two serum samples with normal catalytic concentra-
tion (2.36 U/l and 12.31 U/l respectively); 5'-nu-
cleotidase activity was measured in Solutions of sub-
strate prepared on days 0, 3, 9 and 15. No note-
worthy Variation in this activity was observed.
three serum samples with high catalytic concentra-
tion (28, 36 and 51 U respectively); 5'-nucleoti-
dase activity was measured with Substrate Solutions
prepared on days 0 and 45. Under these conditions,
considerable enzyme activity was lost from all three
samples (60, 70 and 80% respectively).
Correlations
A hundred serum samples were measured by the
method described and the results compared with
thpse obtained by the automated continuous flow
technique üsing an AAI Autoanalyzer (16) (fig. 7).
The correlation was excellent, since the coefficient of
correlation was 0.974. The regression line is defined
by the formula y = 0.85 x-1.5.
The means obtained were 11.8 U/l for the technique
described and 15.6 for the one used for comparison.
Partial correlations were studied on 29 pathological
serum samples (alkaline phosphatase >100 U/l; 5'-
nucleotidase >18 U/l) by the continuous flöw tech-
nique; again the cqrrelation was excellent
(r = 0.974). The regression line formula calculated
was y = 0.94x-6.9.
S 75'
50
! 25
0 25 50 75 100
S ' - N u c l e o t i d a s e (Belf/eld's m e t h o d ) ( U / U
Fig. 7. Correlation study. Comparison of the results for the auto-
mated technique described (y) with those for BelfielcTs co-
lorimetric method (x).
Normal values
Correlations were studied on 69 serum samples from
adult subjects. The samples displayed normal alka-
line phosphatase catalytic concentration (below 17
U/l with the continuous flow technique). Mean
values for the two methods were:
4.7 U/l for the method described, and
6.4 U/l for the continuous flow method.
The highest extreme value for the method described
was 10.9 U/l.
A complementary study made of 14 serum samples
in which 5'-nucleotidase activity reached the upper
limit of the usual values given by the continuous flow
method (between 15 and 20 U/l); for the method
described here, the mean value found was 12.8 U/I.
Consequently, we fixed the upper limit for normal
values at 13 U/l.
Discussion
The principle used here for measuring serum 5'-nu-
cleotidase catalytic activity was originally proposed
by Dooley & Racich and Heinz et al. (12) and repro-
duces in vitro the scheine of purine nucleotide degra-
dation in vivo, up to the uric acid stage, the final Step
of purine catabolism in man. Measurement of the
products of hypoxanthine oxidation by xanthine oxi-
dase (i.e. uric acid or HaOz) permitted calculation of
5'-nucleotidase catalytic activity.
The degradation of inosine 5'-monophosphate to
uric acid was direct and complete, in contrast to that
of adenosine 5'-monophosphate (a Substrate whose
J. Clin. Chem. Clfn? Biochem. / Vol. 21, 1983 / No. 8
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use has been suggested by many authors); most of
the adenosine formed by adenosine S'-monophos-
phate hydrolysis was deaminated by an indirect
route leading to inosine and thence to hypoxanthine
formation; in addition, adenosine degradation to
adenine by the nucleoside phosphorylase System
seems very restricted in man (17).'
Of the two procedures involving the use inosine 5'-
monophosphate (11-12), we thought it preferable
to choose that of Heinz et al. (12), which measures
the H2O2 formed, a product which, unlike uric acid,
is not initially present in the serum.
At the same time, it is not impossible that in hyperu-
ricaemic subjects treated with allopurinol (a power-
ful xanthine oxidase inhibitor) the reaction which
oxidizes hypoxanthine to uric acid might be itihibit-
ed. However, although the serum allopurinol con-
centrations recorded in hyperuricaemic subjects are
sufficient to inhibit liver xanthine oxidase, they
might not suffice to inhibit the xanthine oxidase ac-
tivity introduced into the reaction medium, an activi-
ty about a hundred times that in human liver (13).
Human liver xanthine oxidäse was inhibited by uric
acid (1.6 mmol/1) when xanthine oxidase was the
Substrate (18). In view of the relatively high K\ for
uric acid (1.6 mmol/1), the biological role of uricäe-
mia is not obvious: in very severe hyperuricaemias,
the serum uric acid concentration is far lower than
the Ki.
Adaptation to a Kem-O-Mat transfer analyzer of the
principle of measurement suggested by Heinz et al.
(12) enabled us to redefine some of the method's pa-
rameters.
The inosine 5'-monophosphate concentration chos-
en for the reaction medium corresppnded to 32
times the apparent Km values of the 5'nucleotidase
serum (12 ; fig. 1). This value was comparable
to the one reported by Heinz et al. (30 ). Satu-
rating Substrate concentrations do therefore accu^
rately measure S'-nucleotidase activity. This was
verified by the fact that in serum samples with nor-
mal (13 U/l), the amount of inosine 5'-monophos-
phate transformed in 10 minutes of reaction time did
not exceed 3%, and, for samples with the highest ac-
ceptable catalytic concentration (100 U/l), was nev-
er more than 25%.
The reaction time chosen (10 minutes) was in the
linearity zone. Substrate oxidation kinetics wefe
constant, at least up to 30 minutes of incubation time
(fig. 5).
The preincubation phase made it possible to record
the Variation in the absorbance of the buffer + se-
rum mixture; this value of about 0.012A probably
corresponded to the oxidation of the oxypurines in
the sample by xanthine oxidase. It is logical to as-
sume that the serum oxypurine concentration con-
tributes to the Variation in seruin blank absorbance.
In primary and secondary liver caWcer cases, Rams*
dell & Kelly (19) rjeported hyperoxypurinaemia
combined with hypouricaemia due to lack of xan-
thine oxidase synthesis by the liver. In the case fer-
ported in figure 4, which shpwed ä large Variation in
serum blank absorbance (A = 0.55) and S'-nucleoti-
dase catalytic cpncentratipn of 55 U/l, it is plausible
to connect the high serum blank with the hyperoxy-
purinaemia ässociäted with liver aetiology. In the
very rare cases of xanthine-oxidase deficieney (es-
seiitial xanthinuria), the large rise in blood oxy^
purine will pröbäbly be feflected by a greätef Varia-
tion in serum blank absorbance.
The precision of the method described here is very
satisfactory compared to that of the procedures re=
ported earlieri Fpr an average enzyme catalytic cpn-
centration of 30 U/l, the intraseries coefficients of
Variation were 8% föf the cölörimetfic techniques
(16) and 5% for the enzymatic techniques according
to Ellis et al. (8, 10). In ouf tests, the iiitraseries CV
was 1%.
Between-day jprecision was also excellent with the
present method, compared to that obtained by Doo-
ley's kinetic method (11); this authors foünd a coef-
ficient of Variation of 14%^ where S'-nuclepti-
dase = 53 Ü/l, compared to our figure, which was
close to 5% for 5'-nucleotidä& = 23 U/L
The present linearity limit was fixed at 100 U/1, i.e.
at 8 times the threshPld physiolpgical catalytic activi-
ty concentration. this result is perfectly superimposa-
ble on those pbtained by other methods.
In the coürse Pf our tests, we were unable to define
the linearity of the reaction for enzyme catalytic con-
centrations above 110 U/l.
The usual vajues, determined on 69 samples, ranged
from l to 12 Ü/l (x = 4.70 U/l) and were distmctly
higher thän those repprted by Heinz et al. (1.5 to 2.9
U/l). The latter values do not seem to us represeütä-
tive of a normal popülation, given the small num'ber
of samples analysed.
On the other hand, the mean Pf oür üsüäl values
(x = 4.70 U/l) is very close to the pne obtained by
Belfield's method ( = 6.40 U/l).
Six months of experimentation iii oüir laboratory
enabled us to appreciate the mäin qualities of the
method pfoposed here: reliability 4nd practicability.
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Erstmals Kontrolle
der „Thromboseprophylaxe" mit
niedrig dosiertem Meparin möglich
l/<
,;#r > · > ' .^./
/ s \ '·-··-',/* \ .\ . \.
Subkutan appliziertes Heparin
wird durch zahlreiche Fakto-
ren beeinflußt. Von Patient zu
Patient treten bei einer sche-
.matischen Dosierung unter-
schiedliche Wirkspiegel auf.
In vielen Fällen wird des-
halb kein ausreichender Schutz
erreicht (non-responder).
Die Kontrolle des Heparin-
spiegels bei der Iow dose
Prophylaxe schafft die Vor-
aussetzung für eine individu-
elle Dosierung. Damit wird für
den einzelnen Patienten ein
verbesserter Thromboseschutz
erreicht.
Der >Heparin Iow dose< Test
erfaßt die antithrombotische
Wirkung des subkutan appli-
zierten Hepärins in einem Kon-
zentrationsbereich von 0,01-
0,2 USP-Einheiten/ml Plasma.
In diesem Bereich liegt der
Heparinspiegel unter der Iow
dose Prophylaxe. Mit den bisher
üblichen konventionellen Test-
methoden können diese niedri-
gen Konzentrationen nicht
erfaßt werden.
Coupon
Bitte senden Sie mir ausführliche
Informationen über
>Heparin Iow dose< Test
Name
Straße
PLZ/Ort
Boehringer Mannheim GmbH
Abt. M - D I I
Postfach 3101 20
6800 Mannheim 31
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Complete automation of this technique gives it ra-
pidity (50 determinations per hour) and precision
which are both very satisfactory.
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